First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine
Clinical trial NCT02564146 · COMPLETED
Trial details
- NCT number
- NCT02564146
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2022-03-01
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.